System for high permeability hemodialysis Prismaflex

Manufacturer

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    NIDFSINVIMA

2 devices with a similar name

Learn more about the data here

  • Model / Serial
  • Product Description
    The PRISMAFLEX control unit is indicated for: continuous renal replacement therapy (CRRT) for patients with acute renal failure and / or fluid load. Therapeutic exchange therapy deplasma (TPE) for contrastor patients in whom withdrawal of plasma components is indicated
  • Manufacturer
  • Model / Serial
    PRISMAFLEX SYSTEM, PRISMAFLEX 7.XX Row, PRISMAFLEX 6.10
  • Product Description
    The PRISMAFLEX control unit is indicated for: Continuous Renal Replacement Therapy (CRRT) for Patients Therapeutic Exchange of Plasma (TPE) for patients with disorders in which the withdrawal of the components of the plasma.
  • Manufacturer